The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma

BACKGROUND: Epidermal Growth Factor Receptor (EGFR) molecular analysis is performed to assess the responsiveness to Tyrosine Kinase Inhibitors (TKIs) in patients with Non-Small Cell Lung Cancer (NSCLC). The existence of molecular intra-tumoral heterogeneity has been observed in lung cancers. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: de Biase, Dario, Genestreti, Giovenzio, Visani, Michela, Acquaviva, Giorgia, Di Battista, Monica, Cavallo, Giovanna, Paccapelo, Alexandro, Cancellieri, Alessandra, Trisolini, Rocco, Degli Esposti, Roberta, Bartolini, Stefania, Pession, Annalisa, Tallini, Giovanni, Brandes, Alba A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433779/
https://www.ncbi.nlm.nih.gov/pubmed/28520821
http://dx.doi.org/10.1371/journal.pone.0177822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433779/
https://www.ncbi.nlm.nih.gov/pubmed/28520821
http://dx.doi.org/10.1371/journal.pone.0177822

Ejemplares similares